CAS: 371242-69-2 - IC 87114
Formula:C22H19N7O
InChI:InChI=1S/C22H19N7O/c1-13-6-3-4-9-16(13)29-17(27-15-8-5-7-14(2)18(15)22(29)30)10-28-12-26-19-20(23)24-11-25-21(19)28/h3-9,11-12H,10H2,1-2H3,(H2,23,24,25)
InChI key:InChIKey=GNWHRHGTIBRNSM-UHFFFAOYSA-N
SMILES:O=C1C2=C(N=C(N1C=3C=CC=CC3C)CN4C=NC=5C(=NC=NC54)N)C=CC=C2C
- Synonyms:
- 2-[(6-Aminopurin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one
- 4(3H)-Quinazolinone, 2-[(6-amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-
- Ic-87114
- 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one
- 2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
IC-87114 REF: IN-DA00BYHPCAS: 371242-69-2 | 98% | To inquire | Tue 03 Dec 24 | |
IC87114 REF: 7W-GW8964CAS: 371242-69-2 | - - - | 170.00 €~406.00 € | Tue 10 Dec 24 | |
IC-87114 REF: TM-T2660CAS: 371242-69-2 | 100% - 97.97% | 39.00 €~541.00 € | Tue 10 Dec 24 | |
IC 87114 REF: 3D-FA43322CAS: 371242-69-2 | Min. 95% | To inquire | Tue 14 Jan 25 |
Ref: IN-DA00BYHP
5mg | 148.00 € | ||
25mg | 535.00 € | ||
50mg | 527.00 € | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Ref: 7W-GW8964
1mg | 170.00 € | ||
5mg | 241.00 € | ||
10mg | 406.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
IC-87114
CAS:371242-69-2
IC-87114 is a specific PI3Kδ inhibitor(IC50=0.5 μM).
Formula:
C22H19N7O
Purity:
100% - 97.97%
Color and Shape:
Solid
Molecular weight:
397.43
Ref: TM-T2660
2mg | 39.00 € | ||
5mg | 57.00 € | ||
10mg | 90.00 € | ||
25mg | 144.00 € | ||
50mg | 237.00 € | ||
100mg | 373.00 € | ||
200mg | 541.00 € | ||
1mL*10mM (DMSO) | 63.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
IC 87114
CAS:371242-69-2
Inhibitor of PI3K kinases
Formula:
C22H19N7O
Purity:
Min. 95%
Molecular weight:
397.43 g/mol
Ref: 3D-FA43322
10mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025